Mark McClellan
- Economics and Econometrics top 0.1%
- Healthcare Policy and Management 94
- Health Systems, Economic Evaluations, Quality of Life 65
- Pharmaceutical Economics and Policy 19
- Economic and Financial Impacts of Cancer 13
- General Health Professions top 0.2%
- Primary Care and Health Outcomes 45
- Global Health Care Issues 29
- Healthcare cost, quality, practices 22
- Pharmacy top 0.2%
- Family Practice top 1%
- Statistics and Probability top 0.5%
-
- Heart Failure Treatment and Management 7
- Co-authors
- Joseph P. NewhouseDaniel P. KesslerJ. P. NewhouseElliott S. FisherHaruko NoguchiJoshua S. BennerDavid CutlerMichael G. Shlipak
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mark McClellan
195 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Economics and Econometrics 3.6k
- General Health Professions 3.1k
- Pharmacy 509
- Family Practice 153
- Statistics and Probability 498
Countries citing papers authored by Mark McClellan
This map shows the geographic impact of Mark McClellan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark McClellan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark McClellan more than expected).
Fields of papers citing papers by Mark McClellan
This network shows the impact of papers produced by Mark McClellan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark McClellan. The network helps show where Mark McClellan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark McClellan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | National coronavirus response: A road map to reopening | 2020 | 42 |
| 3 | 2020 | 4 | |
| 4 | 2017 | 4 | |
| 5 | Aligning payment reform and delivery innovation in emergency care. | 2016 | 12 |
| 6 | 2016 | 0 | |
| 7 | Repairing the Broken Market for Antibiotic Innovation | 2015 | 2 |
| 8 | Transforming oncology care: payment and delivery reform for person-centered care. | 2015 | 8 |
| 9 | 2004 | 43 | |
| 10 | Cost-Effectiveness of Positron Emission Tomography for Diagnosis of Solitary Pulmonary Nodules | 2001 | 2 |
| 11 | 2001 | 2 | |
| 12 | The Sources of Cost Difference in Health Insurance Plans: A Decomposition Analysis | 2001 | 2 |
| 13 | How does managed care do it | 2000 | 6 |
| 14 | What Has Increased Medical-Care Spending Bought? | 1998 | 27 |
| 15 | Technological Change in Heart-Disease Treatment: Does High-Tech Mean Low Value? | 1998 | 28 |
| 16 | Econometrics of Outcomes Research, The | 1998 | 3 |
| 17 | Diagnosis and Medicare Expenditures at the End of Life | 1998 | 2 |
| 18 | The Determinants of Technological Change in Heart Attack Treatment | 1996 | 28 |
| 19 | Health Care Technologies and Health Care Choices | 1995 | 4 |
| 20 | Does More Intensive Treatment of Acute Myocardial Infarction Reduce Mortality | 1994 | 28 |
About Mark McClellan
Mark McClellan is a scholar working on Economics and Econometrics, General Health Professions and Family Practice, having authored 202 papers that have together received 7.8k indexed citations. Recurring topics across this work include Healthcare Policy and Management (94 papers), Health Systems, Economic Evaluations, Quality of Life (65 papers), Primary Care and Health Outcomes (45 papers), Global Health Care Issues (29 papers), Healthcare cost, quality, practices (22 papers), Pharmaceutical Economics and Policy (19 papers), Economic and Financial Impacts of Cancer (13 papers) and Heart Failure Treatment and Management (7 papers). The work is most often cited by research in Economics and Econometrics (3.6k citations), General Health Professions (3.1k citations) and Pharmacy (509 citations). Mark McClellan has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Joseph P. Newhouse, Daniel P. Kessler, J. P. Newhouse, Elliott S. Fisher, Haruko Noguchi, Joshua S. Benner, David Cutler, Michael G. Shlipak, Paul A. Heidenreich and Barbara J. McNeil. Their work appears in journals such as Health Affairs, JAMA, New England Journal of Medicine, Circulation Cardiovascular Quality and Outcomes and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.